No Performance Drugs, and Why It Is a Sales Edge

Larry’s stance on performance drugs is blunt: anything that spikes you also drops you, and the drop reads as a tell across a negotiating table. SuperModel, his term for the presence layer of a pitch, depends on a level baseline: steady eyes, calm hands, the listening position held without fidgeting. A stimulant crash in the second hour of a dinner meeting looks exactly like nerves to the person across from you, and nerves erode trust fast.

No Performance Drugs, and Why It Is a Sales Edge

Larry says he would rather be slightly less sharp at minute five and fully present at minute ninety than the other way around. High-ticket deals rarely close on the first offer, they close on the follow-through, and follow-through needs an even keel, not a chemical peak. The pen-drop close, setting the pen down and staying silent until the other side picks it up, does not survive a leg bouncing from too much caffeine.

This isn’t a purity stance for its own sake, it’s a business decision: predictability is the product when you are the product. Karma in Larry’s framework means tracking and channeling goodwill fast, a thank you, a tip, a quick reciprocation, and none of that lands if you’re too wired to notice the moment for it.

A jittery closer misses the read on when to go quiet and when to talk, and that read is most of the job. His claim that he skips stimulants before a big meeting is his account of his own habits, not a study, but the incentive behind it is easy to check: rooms notice state changes.

External API thinking says plug into what already works, and a rested nervous system is the oldest working system there is. The edge isn’t chemical, it’s that the other side can set their watch by how you show up.

No Performance Drugs, and Why It Is a Sales Edge

Details: Larry explains the steady state edge

#PerformanceEdge #SuperModel #Web12

Get the feed in your inbox.

No algorithm. Just mail. #Web12

Discover more from Web12

Subscribe now to keep reading and get access to the full archive.

Continue reading